Old Web
English
Sign In
Acemap
>
authorDetail
>
Seitaro Asahina
Seitaro Asahina
Astellas Pharma
Medicine
Internal medicine
Placebo
Insulin
Type 2 Diabetes Mellitus
5
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study
2019
Diabetology international
Hisamitsu Ishihara
Susumu Yamaguchi
Ikko Nakao
Seitaro Asahina
Taishi Sakatani
Show All
Source
Cite
Save
Citations (5)
ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with EGFR mutation‐positive non‐small‐cell lung cancer
2018
Cancer Science
Koichi Azuma
Makoto Nishio
Hidetoshi Hayashi
Katsuyuki Kiura
Miyako Satouchi
Shunichi Sugawara
Toyoaki Hida
Yasuo Iwamoto
Akira Inoue
Koji Takeda
Satoshi Ikeda
Tomoki Nakagawa
Kentaro Takeda
Seitaro Asahina
Kanji Komatsu
Satoshi Morita
Masahiro Fukuoka
Kazuhiko Nakagawa
Show All
Source
Cite
Save
Citations (3)
Tolerability and antitumor activity of ASP8273 in TKI-naive Japanese subjects with EGFR mutation–positive non-small cell lung cancer.
2017
Journal of Clinical Oncology
Shunichi Sugawara
Koichi Azuma
Makoto Nishio
Hidetoshi Hayashi
Katsuyuki Kiura
Miyako Satouchi
Toyoaki Hida
Atsushi Nakamura
Yasuo Iwamoto
Akira Inoue
Koji Takeda
Satoshi Ikeda
Tomoki Nakagawa
Seitaro Asahina
Kanji Komatsu
Satoshi Morita
Masahiro Fukuoka
Kazuhiko Nakagawa
Show All
Source
Cite
Save
Citations (1)
Pharmacokinetics (PK) and safety of enzalutamide in healthy Chinese males.
2017
Journal of Clinical Oncology
Qian Chen
Yan-Mei Liu
Xiaopeng Zhang
Risa Fukushi
Seitaro Asahina
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study
2016
Diabetes, Obesity and Metabolism
Hisamitsu Ishihara
Susumu Yamaguchi
Ikko Nakao
Akira Okitsu
Seitaro Asahina
Show All
Source
Cite
Save
Citations (36)
1